Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 21, Number 9—September 2015
THEME ISSUE
Emerging Infections Program

Emerging Infections Program

Incidence of Clinician-Diagnosed Lyme Disease, United States, 2005–2010

Christina A. NelsonComments to Author , Shubhayu Saha, Kiersten J. Kugeler, Mark J. Delorey, Manjunath B. Shankar, Alison Hinckley, and Paul S. Mead
Author affiliations: Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (C.A. Nelson, K.J. Kugeler, M.J. Delorey, A.F. Hinckley, P.S. Mead); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Saha, M.B. Shankar)

Main Article

Figure 3

Seasonal distribution of inpatient and outpatient clinician-diagnosed Lyme disease in MarketScan compared with US surveillance cases, 2005–2010. *Because information about hospitalization is not consistently captured by surveillance, US surveillance data include both inpatients and outpatients. †Date of symptom onset for surveillance cases; date of admission or first outpatient visit for MarketScan events.

Figure 3. Seasonal distribution of inpatient and outpatient clinician-diagnosed Lyme disease in MarketScan compared with US surveillance cases, 2005–2010. *Because information about hospitalization is not consistently captured by surveillance, US surveillance data include both inpatients and outpatients. †Date of symptom onset for surveillance cases; date of admission or first outpatient visit for MarketScan events.

Main Article

TOP